ASO Author Reflections: Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma

被引：0
|
作者：
Chan, Wing-Lok [1 ]
机构：
[1] Univ Hong Kong, LKS Fac Med, Dept Clin Oncol, Hong Kong, Peoples R China
来源：
ANNALS OF SURGICAL ONCOLOGY | 2023年 / 30卷 / 02期
关键词：
D O I：
10.1245/s10434-022-12776-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：871 / 872
页数：2
相关论文
共 50 条
  • [1] ASO Author Reflections: Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma
    Wing-Lok Chan
    Annals of Surgical Oncology, 2023, 30 : 871 - 872
  • [2] ASO Visual Abstract: Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma
    Chan, Wing-Lok
    Choi, Cheuk-Wai
    Wong, Ian Yu-Hong
    Tsang, Terence Hon-Ting
    Lam, Adrian Tin-Chung
    Tse, Rosa Pui-Ying
    Chan, K. K.
    Wong, Claudia
    Law, Betty T. T.
    Cheung, Emina Edith
    Chan, Siu-Yin
    Lam, Ka-On
    Kwong, Dora
    Law, Simon
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (02) : 873 - 873
  • [3] Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma
    Wing-Lok Chan
    Cheuk-Wai Choi
    Ian Yu-Hong Wong
    Terence Hon-Ting Tsang
    Adrian Tin-Chung Lam
    Rosa Pui-Ying Tse
    K. K. Chan
    Claudia Wong
    Betty Tze-Ting Law
    Emina Edith Cheung
    Siu-Yin Chan
    Ka-On Lam
    Dora Kwong
    Simon Law
    Annals of Surgical Oncology, 2023, 30 : 861 - 870
  • [4] ASO Author Reflections: Enhancing Treatment Outcomes in Unresectable Esophageal Squamous Cell Carcinoma Through Immunochemotherapy
    Huang, Shujie
    Wang, Sichao
    Gao, Zhen
    Qiao, Guibin
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (10) : 6714 - 6715
  • [5] ASO Author Reflections: Biomarkers for Neoadjuvant Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma
    Hiroshi Okumura
    Masahiro Noda
    Shoji Natsugoe
    Annals of Surgical Oncology, 2018, 25 : 715 - 716
  • [6] ASO Author Reflections: Biomarkers for Neoadjuvant Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma
    Okumura, Hiroshi
    Noda, Masahiro
    Natsugoe, Shoji
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 715 - 716
  • [7] ASO Author Reflections: Esophageal Squamous Cell Carcinoma—Still a Conundrum
    M. Hart Squires
    Jonathan C. Salo
    Annals of Surgical Oncology, 2022, 29 : 1334 - 1335
  • [8] ASO Author Reflections: Prediction of the Response to Neoadjuvant Therapy by Patients with Esophageal Squamous Cell Carcinoma
    Okamura, Akihiko
    Watanabe, Masayuki
    Okui, Jun
    Matsuda, Satoru
    Takemura, Ryo
    Kawakubo, Hirofumi
    Takeuchi, Hiroya
    Muto, Manabu
    Kakeji, Yoshihiro
    Kitagawa, Yuko
    Doki, Yuichiro
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (04) : 2186 - 2187
  • [9] ASO Author Reflections: Serum Squamous Cell Carcinoma Antigen in Recurrent Esophageal Squamous Cell Carcinoma
    Yasukazu Kanie
    Akihiko Okamura
    Masayuki Watanabe
    Annals of Surgical Oncology, 2021, 28 : 7997 - 7998
  • [10] ASO Author Reflections: Serum Squamous Cell Carcinoma Antigen in Recurrent Esophageal Squamous Cell Carcinoma
    Kanie, Yasukazu
    Okamura, Akihiko
    Watanabe, Masayuki
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (12) : 7997 - 7998
12345